Moreover PD-L1 expression on the surface of tumor cells has been correlated with a higher-stage, suggesting good response to PD1/PD-L1 antagonist, although the results of different trials did not observe the association between PD-L1 expression and tumor response rate [22]. The gene discussed is CD274; the disease is neoplasm.